PT  - JOURNAL ARTICLE
AU  - Igor Nesteruk
AU  - Oleksii Rodionov
TI  - The impact of demographic factors on the accumulated number of COVID-19 cases per capita in Europe and the regions of Ukraine in the summer of 2021
AID  - 10.1101/2021.07.04.21259980
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.04.21259980
4099  - http://medrxiv.org/content/early/2021/07/06/2021.07.04.21259980.short
4100  - http://medrxiv.org/content/early/2021/07/06/2021.07.04.21259980.full
AB  - The accumulated number of COVID-19 cases per capita is an important characteristic of the pandemic dynamics that may also indicate the effectiveness of quarantine, testing and vaccination. As this value increases monotonically over time, the end of June 2021 was chosen, when the growth rate in Ukraine and the vast majority of European countries was small. This allowed us to draw some intermediate conclusions about the influence of the volume of population, its density, and the level of urbanization on the accumulated number of laboratory-confirmed cases per capita in European countries and regions of Ukraine. A simple analysis showed that the number of cases per capita does not depend on these demographic factors, although it may differ by about 4 times for different regions of Ukraine and more than 9 times for different European countries. The number of COVID-19 per capita registered in Ukraine is comparable with the same characteristic in other European countries but much higher than in China, South Korea and Japan.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no needAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata is in the text